Swedish Medical Center/Cardiovascular Research

Seattle, Washington 98122

1 studies enrolling now · 5 studies all time

What they study most

Acute Coronary Syndrome, Acute Myocardial Infarction (AMI), Atherosclerotic Cardiovascular Disease, Cardiovascular Disease and Lipoprotein(a), Coronary Artery Disease, Coronary Occlusion

Studies at this site

• An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) — Recruiting now
• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events — Running, not enrolling
• Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD — Running, not enrolling
• AngelMed for Early Recognition and Treatment of STEMI — Completed